Articles From: 2014/11/16 - Allergan, Actavis Near Deal -- 2nd Update to - Regulus and Sanofi Present New Data Enhancing the Preclinical Profile of RG-012, an Anti-miR Targeting microRNA-21 for the Treatment of Renal Dysfunction in Alport Syndrome Patients, at ASN's Kidney Week 2014 Meeting


2014/11/16
By Jonathan D.
Sign-up for 2014/11/16 - Allergan, Actavis Near Deal -- 2nd Update investment picks
2014/11/16
By Daniel Gilbert In its effort to force a merger on Baker Hughes Inc. by replacing its board, Halliburton Co.
Sign-up for 2014/11/16 - For Halliburton, Replacing Baker Board May Not Be Easy investment picks
2014/11/16
By P.R. Venkat Singapore conglomerate Keppel Corp.'s unit, which is looking to raise over 500 million Singapore dollars (US$400 million) in an initial public offering of its data centers, has secured about 10 cornerstone investors for the deal, people with knowledge of the matter said Monday.
Sign-up for 2014/11/16 - Keppel Unit Secures Key Investors for IPO investment picks
Botox maker Allergan Inc. (AGN) and Irish pharmaceutical company Actavis PLC (ACT) are close to a friendly deal, which could be announced as early as Monday, the Wall Street Journal reported Sunday.
Sign-up for - Allergan, Actavis near cash-and-stock deal: WSJ investment picks
2014/11/16
By Daniel Gilbert HOUSTON --
Sign-up for 2014/11/16 - Investigators to probe DuPont's deadly Texas chemical leak investment picks
The Medicines Company (NASDAQ:MDCO) today presented findings from a new Phase 1 study showing that a single infusion of MDCO-216, an investigational lipid-modifying agent, in both healthy and CAD patients, modified key lipid parameters including ApoA-1, phospholipids, HDL, pre-beta 1 HDL and Apo E, markedly increased ABCA1 mediated efflux, a potential marker of reverse cholesterol transport and was well tolerated.
Sign-up for - The Medicines Company Presents New Phase 1 Data Showing Investigational Agent MDCO-216 Modified Key Lipid Parameters and Was Well-Tolerated in Healthy and Coronary Artery Disease (CAD) Patients investment picks
2014/11/16
By Qu Yunxu BEIJING (Caixin Online) -- Alibaba Group Holding Ltd.'s (BABA) annual e-commerce frenzy smashed last year's record, but company executives were not exactly ecstatic.
Sign-up for 2014/11/16 - Alibaba and the truth behind the Singles Day sales numbers investment picks
AstraZeneca (NYSE: AZN) today presented top-line results of two pivotal Phase III trials investigating the potential of lesinurad, a selective uric acid re-absorption inhibitor (SURI), when used in combination with xanthine oxidase (XO) inhibitor allopurinol.
Sign-up for - AstraZeneca Presents Data from Phase III Studies of Lesinurad in Combination with Allopurinol in Gout Patients at American College of Rheumatology 2014 Annual Meeting investment picks
2014/11/16
By Matt Wirz Ukraine's deputy prime minister was in a bind when he came to the San Mateo, Calif., office of mutual-fund manager Michael Hasenstab in January 2013.
Sign-up for 2014/11/16 - Michael Hasenstab Bets Big in Controversial Places investment picks
2014/11/16
By Esther Fung SHANGHAI--Chinese property developer Evergrande Real Estate Group Ltd plans to invest around HK$950 million ($122.5 million) for a controlling stake in a Hong Kong-based magazine publisher, New Media Group Holdings--its latest foray in a new business line as the firm looks to diversify to cushion the risks from a weakened property market.
Sign-up for 2014/11/16 - China's Evergrande Group Buys Publisher as Diversification Continues investment picks
2014/11/16
He made a huge profit as Ireland and Poland muddled through the crisis--and gained a reputation among government leaders as a white-knight investor.
Sign-up for 2014/11/16 - Michael Hasenstab Bets Big in Controversial Places -2- investment picks
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for three students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation’s premier research competition for high school students.
Sign-up for - Arizona and New Mexico High School Scientists Win Regional Siemens Competition at the University of Texas at Austin for Research on Intrinsically Disordered Proteins for Drug Discovery and Computational Models of Tree Growth investment picks
2014/11/16
Includes partnership to expand commercialization of aerospace composites Longtime Boeing supplier rewarded for commitment to Partnering for Success TOKYO , Nov.
Sign-up for 2014/11/16 - Boeing, Toray Industries Reach Agreement on Composites for 777X Wings investment picks
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trading in Monday's session are Tyson Foods Inc., Urban Outfitters Inc. and Agilent Technologies Inc. Tyson Foods (TSN) is projected to post fiscal fourth-quarter earnings of 76 cents a share, according to a consensus survey by FactSet.
Sign-up for - UPDATE: Tyson, Urban Outfitters, Agilent earnings in focus investment picks
2014/11/16
By Gregor Stuart Hunter Investors poured money into China's stock market Monday on the first day of trading in a program that opened up the country's markets to trading through Hong Kong.
Sign-up for 2014/11/16 - Money Surges Into Shanghai Stocks on Stock Connect's First Day -- Update investment picks
2014/11/16
By Wallace Witkowski, MarketWatch Home Depot, Lowe's, Target report results SAN FRANCISCO (MarketWatch) -- Earnings season wraps up this week as the last Dow component and most of the remaining S&P 500 companies report.
Sign-up for 2014/11/16 - MARKET SNAPSHOT: Retailers Close Out Earnings Season investment picks
AUSTIN, Texas , Nov.
Sign-up for - Hanger Postpones Release of Third Quarter 2014 Financial Results investment picks
2014/11/16
By Wallace Witkowski, MarketWatch Home Depot, Lowe's, Target report results SAN FRANCISCO (MarketWatch) -- Earnings season wraps up this week as the last Dow component and most of the remaining S&P 500 companies report.
Sign-up for 2014/11/16 - UPDATE: Retailers close out earnings season investment picks
2014/11/15
The Estée Lauder brand today announced that it has signed Kendall Jenner, fashion’s new breakout star and social media sensation.
Sign-up for 2014/11/15 - Estée Lauder Signs Model of the Moment and Social Media Phenomenon Kendall Jenner investment picks
2014/11/15
By Dan Neil All right, all right, all right! Lincoln and Matthew McConaughey are going steady.
Sign-up for 2014/11/15 - Lincoln revival: 2015 MKC dances with the stars investment picks
2014/11/15
France won't kick off its planned asset sales by disposing of shares in Electricite de France SA, the French economy minister Emmanuel Macron said in a newspaper interview published Saturday.
Sign-up for 2014/11/15 - France Won't Start Asset Sale With EDF Shares -- Report investment picks
2014/11/15
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979265003&sourceType=1 http://media3.marketwire.com/logos/20120516-SHORE0516.jpg CALGARY, ALBERTA --
Sign-up for 2014/11/15 - CORRECTION FROM SOURCE: Shoreline Energy Corp. Announces Financial and Operating Results for the Third Quarter 2014 and Asset Sale Update investment picks
2014/11/15
By Quentin Fottrell, MarketWatch Facebook (FB) Chief Executive Mark Zuckerberg dropped out of Harvard University, and yet became a billionaire before this 30th birthday.
Sign-up for 2014/11/15 - UPDATE: 10 business schools that churn out billionaires investment picks
2014/11/15
By Ryan Dezember Martin Craighead's ascent to the upper levels of Baker Hughes Inc.'s management came as the oilfield-service company swallowed a rival to better compete with larger companies Halliburton Co.
Sign-up for 2014/11/15 - Baker Hughes Lifer Defends His Firm investment picks
2014/11/15
By Quentin Fottrell, MarketWatch It's the fastest-growing online retail day of the year There's no need to worry about shoppers brandishing pepper spray this year: Black Friday is moving online.
Sign-up for 2014/11/15 - UPDATE: Once a blood sport, Black Friday moves online investment picks
2014/11/15
By Quentin Fottrell, MarketWatch Once the purveyor of all things free and often the subject of copyright infringements due to consumers uploading videos, Google Inc.'s (GOOG) YouTube is starting a music subscription service for $9.99 a month, which is the same price as music-streaming services like Spotify.
Sign-up for 2014/11/15 - UPDATE: 5 things that used to be free (but aren't anymore) investment picks
- Treatment with RG-012 Protects Kidney Function and Demonstrates Additive Therapeutic Effect with Emerging Standard of Care in Preclinical Model of Alport Syndrome - LA JOLLA, Calif.
Sign-up for - Regulus and Sanofi Present New Data Enhancing the Preclinical Profile of RG-012, an Anti-miR Targeting microRNA-21 for the Treatment of Renal Dysfunction in Alport Syndrome Patients, at ASN's Kidney Week 2014 Meeting investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: 2014/11/16 - Allergan, Actavis Near Deal -- 2nd Update to - Regulus and Sanofi Present New Data Enhancing the Preclinical Profile of RG-012, an Anti-miR Targeting microRNA-21 for the Treatment of Renal Dysfunction in Alport Syndrome Patients, at ASN's Kidney Week 2014 Meeting
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent